OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2022
(7)
2021
(5)
2025
(4)
2023
(3)
2024
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.
Not available
S-EPMC11304118
|
biostudies-literature
Cite
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
Not available
S-EPMC9187316
|
biostudies-literature
Cite
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.
Not available
S-EPMC11071577
|
biostudies-literature
Cite
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.
Not available
S-EPMC12165847
|
biostudies-literature
Cite
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Not available
S-EPMC11882944
|
biostudies-literature
Cite
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Not available
S-EPMC9862219
|
biostudies-literature
Cite
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome.
Not available
S-EPMC8387946
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets